Normal view
-
Journal of Medical Internet Research
-
Anonymization of Portuguese Clinical Notes Using Large Language Models and Quantum-Enhanced Hybrid Architectures: Comparative Evaluation Study
Background: The widespread adoption of electronic health records (EHRs) has generated large-scale repositories of highly sensitive clinical information, emphasizing the need for robust anonymization strategies to enable secondary use for research while safeguarding patient privacy. Conventional rule-based and machine learning approaches for deidentifying medical text face limitations with the linguistic complexity, variability, and context dependence inherent to clinical documentation. Recent ad
-
npj Digital Medicine
-
Publisher Correction: A scoping review on the mental health harms of LLM-based chatbots
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03240-xPublisher Correction: A scoping review on the mental health harms of LLM-based chatbots
Publisher Correction: A scoping review on the mental health harms of LLM-based chatbots
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03240-x
Publisher Correction: A scoping review on the mental health harms of LLM-based chatbots-
npj Digital Medicine
-
Data-driven identification of repurposable drugs for ALS
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03225-wData-driven identification of repurposable drugs for ALS
Data-driven identification of repurposable drugs for ALS
npj Digital Medicine, Published online: 14 September 2026; doi:10.1038/s41746-026-03225-w
Data-driven identification of repurposable drugs for ALS-
Nature Cancer
-
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9
Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.-
Nature Medicine
-
Rethinking the global health system for a new international order
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04622-0In this Comment, we argue for a global health system that recognizes and supports countries as the primary agents of action, oriented around global public goods and collective action, and served by a leaner set of global and regional institutions. We present a potential vision for the functions and distribution of labor in the system to inform ongoing reform discussions and draw critique, dissent and amendment.
Rethinking the global health system for a new international order
Nature Medicine, Published online: 14 September 2026; doi:10.1038/s41591-026-04622-0
In this Comment, we argue for a global health system that recognizes and supports countries as the primary agents of action, oriented around global public goods and collective action, and served by a leaner set of global and regional institutions. We present a potential vision for the functions and distribution of labor in the system to inform ongoing reform discussions and draw critique, dissent and amendment.-
Nature Medicine
-
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04642-wIn the randomized phase 2 ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma (MM) showed higher rates of complete clinical responses in response to treatment with teclistamab compared with lenalidomide–dexamethasone, although longer follow-up is required to determine durable prevention of progression to MM.
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
Nature Medicine, Published online: 11 September 2026; doi:10.1038/s41591-026-04642-w
In the randomized phase 2 ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma (MM) showed higher rates of complete clinical responses in response to treatment with teclistamab compared with lenalidomide–dexamethasone, although longer follow-up is required to determine durable prevention of progression to MM.-
AAAS: Table of Contents
-
Glycan recognition by a plant damage-sensing immune receptor
Science, Ahead of Print.
Glycan recognition by a plant damage-sensing immune receptor
-
Journal of Medical Internet Research
-
“Small” Large Language Models in the Hospital: Evaluation Study on Real-World Data in a Resource-Constrained Setting
Background: Large language models (LLMs) are increasingly being deployed in health care, but their use and deployment in many real-world hospital environments pose significant challenges and concerns. In particular, state-of-the-art commercial models store or process data externally, which is often in conflict with ensuring patient data protection. At the same time, using LLMs locally is limited by the lack of available computing infrastructure. Small open-source LLMs that do not require substan
“Small” Large Language Models in the Hospital: Evaluation Study on Real-World Data in a Resource-Constrained Setting
-
Nature - Issue - nature.com science feeds
-
Breaking timescales with generative sampling of conformational transitions
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11025-1A generative committor-guided path-sampling framework reconstructs rare biomolecular transition pathways and reveals the underlying thermodynamics and kinetics without using predefined collective variables or brute-force sampling, at an acceptable computational cost.
Breaking timescales with generative sampling of conformational transitions
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11025-1
A generative committor-guided path-sampling framework reconstructs rare biomolecular transition pathways and reveals the underlying thermodynamics and kinetics without using predefined collective variables or brute-force sampling, at an acceptable computational cost.-
Nature - Issue - nature.com science feeds
-
Neocortical long-range inhibition promotes cortical synchrony and sleep
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10876-yIn mice, a sparse population of sleep-active long-range inhibitory neurons in the neocortex promote widespread cortical synchronization and sleep, revealing a cortical mechanism that contributes to the regulation of sleep.
Neocortical long-range inhibition promotes cortical synchrony and sleep
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10876-y
In mice, a sparse population of sleep-active long-range inhibitory neurons in the neocortex promote widespread cortical synchronization and sleep, revealing a cortical mechanism that contributes to the regulation of sleep.-
Nature - Issue - nature.com science feeds
-
Denisovans from southwestern China and their subsistence strategies
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10997-4Evidence from Bianfu Cave shows specialized hunting, expedient stone-tool production and extensive bone use of Denisovans, providing new insights into their ecology, behaviour and cultural legacy in eastern Asia.
Denisovans from southwestern China and their subsistence strategies
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10997-4
Evidence from Bianfu Cave shows specialized hunting, expedient stone-tool production and extensive bone use of Denisovans, providing new insights into their ecology, behaviour and cultural legacy in eastern Asia.-
Nature - Issue - nature.com science feeds
-
Integrated signatures define mutational processes in prostate cancer
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10468-wEight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.
Integrated signatures define mutational processes in prostate cancer
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10468-w
Eight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.-
Nature - Issue - nature.com science feeds
-
Proximity-guided graph learning reveals tumour-associated proximity antigens
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11003-7A proximity-mapping atlas defines tumour-associated proximity antigens, revealing disease-associated membrane spatial communities, and identifies EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.
Proximity-guided graph learning reveals tumour-associated proximity antigens
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-11003-7
A proximity-mapping atlas defines tumour-associated proximity antigens, revealing disease-associated membrane spatial communities, and identifies EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.-
Nature Medicine
-
Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
Nature Medicine, Published online: 09 September 2026; doi:10.1038/s41591-026-04615-zIn a phase 2 randomized clinical trial, treatment with the myeloperoxidase (MPO) inhibitor mitiperstat, intended to target the neutrophil–MPO inflammatory pathway, did not improve symptoms or exercise function in individuals with heart failure with preserved or mildly reduced ejection fraction.
Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
Nature Medicine, Published online: 09 September 2026; doi:10.1038/s41591-026-04615-z
In a phase 2 randomized clinical trial, treatment with the myeloperoxidase (MPO) inhibitor mitiperstat, intended to target the neutrophil–MPO inflammatory pathway, did not improve symptoms or exercise function in individuals with heart failure with preserved or mildly reduced ejection fraction.-
npj Digital Medicine
-
Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trial
npj Digital Medicine, Published online: 09 September 2026; doi:10.1038/s41746-026-03111-5Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trial
Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trial
npj Digital Medicine, Published online: 09 September 2026; doi:10.1038/s41746-026-03111-5
Impact of LLM assistance on physician decision-making: a multi-country randomized controlled trial-
Journal of Medical Internet Research
-
Designing a Gamified mHealth App for HIV Prevention and Comorbidities Among Malaysian Young Men Who Have Sex With Men: An Interdisciplinary Expert Panel Study
Background: New HIV cases among Malaysian men who have sex with men continue to rise, with young men who have sex with men (YMSM) accounting for 44% of new infections and experiencing high rates of comorbidities. Mobile health (mHealth) apps offer a promising approach to addressing these challenges by providing discreet access to health information, screening tools, and linkage to services. Given the near-universal smartphone ownership among Malaysian YMSM and high levels of mobile gaming engage
Designing a Gamified mHealth App for HIV Prevention and Comorbidities Among Malaysian Young Men Who Have Sex With Men: An Interdisciplinary Expert Panel Study
-
Nature - Issue - nature.com science feeds
-
Author Correction: AhR inhibition promotes axon regeneration via a stress–growth switch
Nature, Published online: 07 September 2026; doi:10.1038/s41586-026-11103-4Author Correction: AhR inhibition promotes axon regeneration via a stress–growth switch
Author Correction: AhR inhibition promotes axon regeneration via a stress–growth switch
Nature, Published online: 07 September 2026; doi:10.1038/s41586-026-11103-4
Author Correction: AhR inhibition promotes axon regeneration via a stress–growth switch-
Cell
-
Sexual dimorphism in the complete Drosophila male central nervous system connectome
The Drosophila whole male central nervous system connectome enables end-to-end analysis of sensorimotor circuits. Comparison with existing female datasets shows that brain-wide wiring differences between the sexes are concentrated in higher centers.
Sexual dimorphism in the complete Drosophila male central nervous system connectome
-
Nature Cancer
-
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Nature Cancer, Published online: 01 September 2026; doi:10.1038/s43018-026-01243-xPublisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Nature Cancer, Published online: 01 September 2026; doi:10.1038/s43018-026-01243-x
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial-
Oncogene - Issue - nature.com science feeds
-
Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer
Oncogene, Published online: 01 September 2026; doi:10.1038/s41388-026-03969-5Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer
Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer
Oncogene, Published online: 01 September 2026; doi:10.1038/s41388-026-03969-5
Neuromedin U ‘innervation’ reprograms myeloid immunosuppression in neuroendocrine prostate cancer